Utility of COVID-19 Screening in Cancer Patients
Ce dossier présente un ensemble d'articles concernant la prise en charge des cancers durant la crise sanitaire liée au COVID-19
Cancer patients are at increased risk from COVID-19. A number of guidelines advise screening patients undergoing chemotherapy. We analyzed 1,988 tests in 1,226 patients from April 3, 2020, to June 22, 2020, as part of the UK Birmingham Chemotherapy Cancer COVID-19 cohort. Uptake of screening was 98.2%, with an asymptomatic infection prevalence of 0.6%. We conclude that where the incidence of asymptomatic infection is low and patients can be identified early, screening enables the confidence to safely deliver effective cancer care in the era of COVID-19.(...)
Cancer Cell , article en libre accès, 2019